Key Financial Data Of Group

Oncolys BioPharma Inc. - Filing #7609193

Concept 2022-01-01 to
2022-03-31
As at
2022-03-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-03-31
As at
2021-03-31
Key financial data of group
Business results of group
Net sales
193,125,000 JPY
642,494,000 JPY
62,603,000 JPY
Ordinary profit (loss)
-349,628,000 JPY
-1,500,888,000 JPY
-349,626,000 JPY
Net assets
2,979,275,000 JPY
3,593,992,000 JPY
4,768,839,000 JPY
Total assets
3,856,416,000 JPY
4,291,876,000 JPY
5,463,183,000 JPY
Basic earnings (loss) per share
-18.98
-95.50
-22.36
Diluted earnings per share
Equity-to-asset ratio
0.771 xbrli:pure
0.836 xbrli:pure
0.871 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.